Allosteric Modulation of Acetylcholinesterase Activity by Peripheral Ligands Involves a Conformational Transition of the Anionic Subsite

• Published in: Biochemistry (Easton) Vol. 34; no. 47; pp. 15444 - 15452
• Main Authors: Barak, Dov, Ordentlich, Arie, Bromberg, Avraham, Kronman, Chanoch, Marcus, Dino, Lazar, Arie, Ariel, Naomi, Velan, Baruch, Shafferman, Avigdor
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 28.11.1995
• Subjects: Acetylcholinesterase - chemistry; Acetylcholinesterase - metabolism; Allosteric Regulation; Anions - chemistry; Binding Sites; Cysteine - chemistry; Cysteine - genetics; Enzyme Activation; Humans; Ligands; Mutagenesis, Site-Directed; Propidium - metabolism; Protein Conformation
• ISSN: 0006-2960; 1520-4995
• DOI: 10.1021/bi00047a008

Replacement of residues Asp74, Trp286, and Tyr72, which are constituents of the peripheral anionic site (PAS) of human acetylcholinesterase (HuAChE), affected similarly both the binding and the inhibition constants of the PAS-specific ligand propidium, demonstrating that changes in the inhibitory activity are a direct consequence of altered binding to the PAS. In contrast, the active center HuAChE mutants W86A and Y133A show respective 350- and 25-fold increased resistance to inhibition by propidium but no change in binding affinities, demonstrating that the allosteric mechanism of PAS-mediated inhibition involves a conformational change of these Trp86 and Tyr133 residues rather than physical obstruction of substrate access by the inhibitor itself. These findings support the recent proposal that the allosteric mechanism operates via transition between active and nonactive conformations of the anionic subsite Trp86 and that replacement of Tyr133 by alanine may stabilize a nonactive Trp86 conformation that occludes the active center [Ordentlich et al. (1995) J. Biol. Chem. 270, 2082]. In further support of this mechanism and the role of Tyr133, we find that (a) the dissociation constants (Kd) for the noncovalent complexes of the irreversible inhibitors diisopropyl phosphorofluoridate or paraoxon with Y133A HuAChE are increased 20-500-fold, relative to either wild-type enzyme or its Y133F or W86A mutants; and (b) access of substrates such as 3,3-dimethylbutyl thioacetate is restored by removal of Trp86 from the Y133A enzyme (i.e., the W86A/Y133A mutant). We suggest that the conformational transition of Trp86 is coupled to the motions of the cysteine loop (Cys69-Cys96) of HuAChE and is inherent to the dynamics of the native enzyme.